Register

Browse Companies:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
0 1 2 3 4 5 6 7 8 9
Top 10 Penny Stocks
Symbol: Price: Chg %: Volume:
SWET 0.0002 100 40600500
GMNI 0.0002 0 30000000
EVSV 0.0002 0 22478766
FFFC 0.0002 100 19144842
DNAX 0.0002 0 14950000
MYFT 0.0002 0 13156231
IBRC 0.0002 0 10528801
URHN 0.0002 100 10111200
ILIV 0.0002 0 6316847
GNPT 0.0002 0 6100000
EVRM 0.0002 0 5230000
TCEL 0.0002 0 5046999
PURO 0.0002 0 3500000
SLNN 0.0002 0 2784152
DBMM 0.0002 0 2500000
VGPR 0.0002 0 2410322
SVFC 0.0002 0 2180000
DOLV 0.0002 0 2030000
HCEI 0.0002 0 2018802
BRWC 0.0002 0 1799999
QEDN 0.0002 0 1500000
CTYX 0.0002 0 1275000
MHCC 0.0002 0 1250000
MHCC 0.0002 0 1250000
MSSI 0.0002 0 1120500
CEFLF 0.0002 0 1000000
HYGN 0.0002 0 714313
FDFT 0.0002 0 698350
NXMR 0.0002 0 500000
VTPI 0.0002 0 485002

0001 Stocks

Sort By: Date Alphabetically

MultiCell Technologies, Inc. (MCET) Loses Momentum After Recent Climb

Thumbnail
MultiCell Technologies, Inc. (MCET) spiked last Monday after a press release came out, announcing the company had been granted a U.S. patent covering novel drug compositions and platform technologies used for fighting virus infection and cancer. MCET climbed by 57% in price on a 750 thousand share volume at a $846,1 thousand trade value. These were the highest numbers for the company in over five months and the first significant increase since late March. The next day, however, the ticker suffered... more

Bergio International, Inc. (BRGO) Files 10-Q To Report No Progress

Thumbnail
On Thursday, Bergio International, Inc. (BRGO) managed to timely submit its 10-Q for the period ended June 30, 2014. The next day, BRGO issued a press release in which it commented on the results from the report. As can be seen in the filing, the financials did not account for much progress made by the company: Cash: $65,1 thousand Total current assets: $2,1 million Total current liabilities: $879,1 thousand Revenues: $361,1 thousand Net loss: $580,1 thousand In the press release from August 15, BRGO... more

Puramed Bioscience, Inc. (PMBS) Back To Triple Zero Bottom

Thumbnail
Puramed Bioscience, Inc. (PMBS) ended last week with a slide down, lowering the price back to the $0.0001 mark. PMBS's efforts have had no success in maintaining a long-lasting interest in the company. The price of PMBS' stock has been low throughout recent events. The announcements about the company's plans for future development have been insufficient to halt the decline. PMBS' downfall began after an 8-K issued on July 11 reported about a number of decisions that shareholders seemingly did not approve... more

mPhase Technologies, Inc. (XDSL) Sinks Further Down

Thumbnail
The efforts mPhase Technologies, Inc. (XDSL) has made to attract investors' interest lately have had no reaction on the market. XDSL recently reported a growth in revenues in the last quarter of its fiscal year ended June 30, 2014. The company stated in a press release issued on August 5 that its revenues have grown by approximately 6% compared to the previous quarter. We can take a look at XDSL's 10-Q for the period ended March 31, 2014 to see what this would translate into: Cash: $87,4 thousand Total... more
First 1 2 3 4 5 6 7 8 9 10 >> Last